Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?
被引:71
作者:
Barzilai, A
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, IsraelTel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel
Barzilai, A
[1
]
Melamed, E
论文数: 0引用数: 0
h-index: 0
机构:Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel
Melamed, E
Shirvan, A
论文数: 0引用数: 0
h-index: 0
机构:Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel
Shirvan, A
机构:
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel
[2] Rabin Med Ctr, Dept Neurol, Tel Aviv, Israel
[3] Rabin Med Ctr, Felsenstein Med Res Inst, Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
Parkinson's disease is a progressive neurological disease caused by rather selective degeneration of the dopaminergic neurons in the substantia nigra. Though subject to intensive research, the etiology of this nigral loss is still undetermined and treatment is basically symptomatic. The current major hypothesis is that nigral neuronal death in PD is due to excessive oxidative stress generated by auto and enzymatic oxidation of the endogenous neurotransmitter dopamine (DA), the formation of neuromelanin (MM) and the presence of a high concentration of iron. In this review article although we concisely describe the effects of NM and iron on neuronal survival, we mainly focus on the molecular mechanisms of DA-induced apoptosis, DA exerts its toxic effects through its oxidative metabolites either in vitro or in vivo The oxidative metabolites then activate a very intricate web of signals, which culminate in cell death. The signal transduction pathways and genes, which are associated with DA toxicity are described in detail.
机构:
TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAELTECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAEL
BENSHACHAR, D
;
ZUK, R
论文数: 0引用数: 0
h-index: 0
机构:
TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAELTECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAEL
ZUK, R
;
GLINKA, Y
论文数: 0引用数: 0
h-index: 0
机构:
TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAELTECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAEL
机构:
TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAELTECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAEL
BENSHACHAR, D
;
ZUK, R
论文数: 0引用数: 0
h-index: 0
机构:
TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAELTECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAEL
ZUK, R
;
GLINKA, Y
论文数: 0引用数: 0
h-index: 0
机构:
TECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAELTECHNION ISRAEL INST TECHNOL, BRUCE RAPPAPORT FAC MED, DEPT PHARMACOL, IL-31096 HAIFA, ISRAEL